Hysterectomy rate following endometrial ablation in Ontario: a cohort analysis of 76,446 patients
McGee J, McClure A, Ilnitsky S, Vilos A, Abu-Rafea A, Vilos G. Facts Views Vis Obgyn. 2024; 16(3):311-316. Epub 2024 Sep 30.
Publications
Evaluating real world health system resource utilization and costs for a risk-based breast cancer screening approach in the Canadian PERSPECTIVE Integration and Implementation project
Seung SJ, Mittmann N, Ante Z, Liu N, Blackmore KM, Richard ES, Wong A, Walker MJ, Earle CC, Simard J, Chiarelli AM. Cancers (Basel). 2024; 16(18):3189.
Impact of wait time from preoperative CT to pancreatectomy on overall survival for patients with pancreatic carcinoma
Shahi N, Alaref A, Cerasuolo JO, Akhtar-Danesh N, Caswell JM, Serrano PE, Meyers BM, Savage DW, Nelli J, Patlas MN, Siltamaki D, Alabousi A, Siddiqui R, van der Pol CB. Can Assoc Radiol J. 2024; Sep 6 [Epub ahead of print].
Improving the clinical utility of platelet count for cancer detection in primary care: a cohort study in England, Canada, and Australia
Mounce LTA, Calitri R, Hamilton W, Rafiq M, Emery JD, Giannakeas V, Kotsopoulos J, Bailey SER. Cancers (Basel). 2024; 16(17):3074.
Impact of structured multicentre enhanced recovery after surgery (ERAS) protocol implementation on length of stay after colorectal surgery
Bayat Z, Govindarajan A, Victor JC, Kennedy ED. BJS Open. 2024; 8(5):zrae094.
The impact of the Ontario quality-based procedures funding model on radical prostatectomy outcomes
Motamedi N, McClure A, Power NE, Pautler S, Gien L, Welk B, McGee J. Can Urol Assoc J. 2024; 18(9):E269-E275.
Impact of travel distance on short-term outcomes in patients receiving treatment for urolithiasis: a population-based study
Jenkins D, Hosier G, Whitehead M, Beiko D, McGregor T, Nashed J, Siemens DR. Can Urol Assoc J. 2024; Aug 30 [Epub ahead of print].
The impact of perioperative transfusions on the oncologic outcomes of patients with ovarian cancer: a population-based study
Bouchard-Fortier G, Gien LT, Chan WC, Lin Y, Krzyzanowska MK, Ferguson SE. J Surg Oncol. 2024; Aug 27 [Epub ahead of print].
5-alpha reductase inhibitors and prostate cancer mortality
Hamilton RJ, Chavarriaga J, Khurram N, Lau C, Luo J, Liu N, Komisarenko M, Kulkarni G, Wallis C, Juurlink DN, Fleshner N, Finelli A. JAMA Netw Open. 2024; 7(8):e2430223.
Comparing the clinical trial efficacy versus real-world effectiveness of treatments for multiple myeloma: a population-based study
Visram A, Chan KK, Seow H, Pond G, Gayowsky A, Mohyuddin GR, McCurdy A, Sandhu I, Venner C, Lancman G, Balitsky A, Kouroukis T, Bruins R, Kumar S, Fonseca R, Mian H. Haematologica. 2024; Aug 22. [Epub ahead of print].